PRESS RELEASE: July 8, 2024 (Hamilton, New Jersey)
We are excited to announce the appointment of Mr. Sandip Patel as the Chief Executive Officer (CEO) of BIOVERIC Pharmaceuticals, Inc. Mr. Patel brings a wealth of experience and a proven track record of drug product development and commercialization in the pharmaceutical industry. His expertise in patient-centric drug development and commitment to innovation aligns perfectly with our mission and vision.
Mr. Patel expressed his enthusiasm about joining BIOVERIC Pharmaceuticals, Inc. stating, “I am honored to lead such a dynamic company. I look forward to building a team and working with the partners at BIOVERIC Pharmaceuticals to develop innovative, patient-focused drug products that improve healthcare outcomes.”
Please join us in welcoming Mr. Sandip Patel to his new role as CEO of BIOVERIC Pharmaceuticals, Inc.